Cytokinetics (CYTK) News Today $55.98 -1.80 (-3.12%) As of 11:46 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CYTK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Cytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,105 Shares of StockOctober 22 at 5:18 AM | insidertrades.comCytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,105 SharesOctober 21 at 7:54 PM | marketbeat.comCYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud LawsuitOctober 21 at 7:27 PM | prnewswire.comCytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitOctober 21 at 5:04 PM | prnewswire.comCytokinetics price target raised to $62 from $56 at BofAOctober 21 at 2:44 PM | msn.comBank of America Securities Sticks to Their Hold Rating for Cytokinetics (CYTK)October 21 at 9:43 AM | theglobeandmail.comLevi & Korsinsky Reminds Cytokinetics, Incorporated Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTKOctober 21 at 9:00 AM | prnewswire.comShareholders that lost money on Cytokinetics, Incorporated(CYTK) Urged to Join Class Action – Contact Levi & Korsinsky to Learn MoreOctober 20 at 4:20 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTKOctober 20 at 12:43 PM | globenewswire.comContact The Gross Law Firm by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated(CYTK)October 20 at 8:45 AM | prnewswire.comCytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTKOctober 20 at 3:34 AM | prnewswire.comCYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law FirmOctober 20 at 2:47 AM | prnewswire.comROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTKOctober 19 at 7:32 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines - CYTKOctober 18, 2025 | prnewswire.comTD Asset Management Inc Buys 97,464 Shares of Cytokinetics, Incorporated $CYTKOctober 18, 2025 | marketbeat.comCytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTKOctober 17, 2025 | prnewswire.comInsider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells $300,150.00 in StockOctober 17, 2025 | marketbeat.comCytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTKOctober 17, 2025 | theglobeandmail.comCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)October 17, 2025 | globenewswire.comCytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitOctober 17, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTKOctober 17, 2025 | globenewswire.comCytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CYTKOctober 17, 2025 | prnewswire.comCytokinetics (NASDAQ:CYTK) CEO Sells $300,150.00 in StockOctober 17, 2025 | insidertrades.comROSEN, A LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTKOctober 16, 2025 | globenewswire.comClass Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join – Contact The Gross Law FirmOctober 16, 2025 | globenewswire.comDeadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitOctober 16, 2025 | globenewswire.comCYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitOctober 16, 2025 | globenewswire.comFaruqi & Faruqi Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTKOctober 16, 2025 | globenewswire.comThe Gross Law Firm Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTKOctober 16, 2025 | prnewswire.comCytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTKOctober 15, 2025 | globenewswire.comCytokinetics (NASDAQ:CYTK) Hits New 1-Year High - Here's WhyOctober 15, 2025 | marketbeat.comCytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitOctober 15, 2025 | prnewswire.comCYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CytokineticsOctober 15, 2025 | prnewswire.comCytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTKOctober 14, 2025 | globenewswire.comCYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud LawsuitOctober 14, 2025 | prnewswire.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTKOctober 13, 2025 | globenewswire.comClass Action Filed Against Cytokinetics, Incorporated (CYTK) Seeking Recovery for Investors – Contact The Gross Law FirmOctober 13, 2025 | globenewswire.comNovember 17, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against CYTKOctober 13, 2025 | prnewswire.comAberdeen Group plc Buys 320,508 Shares of Cytokinetics, Incorporated $CYTKOctober 13, 2025 | marketbeat.comCYTK INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CytokineticsOctober 12, 2025 | globenewswire.comCytokinetics, Incorporated $CYTK Stake Boosted by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.October 12, 2025 | marketbeat.comNovember 17, 2025 Deadline Approaching: Join Class Action Against Cytokinetics, Incorporated (CYTK) - Contact Levi & KorsinskyOctober 11, 2025 | theglobeandmail.comShareholders That Lost Money on Cytokinetics, Incorporated (CYTK) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreOctober 11, 2025 | theglobeandmail.comCytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTKOctober 10, 2025 | prnewswire.comROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTKOctober 10, 2025 | globenewswire.comInvestors who lost money on Cytokinetics, Incorporated(CYTK) should contact Levi & Korsinsky about pending Class Action - CYTKOctober 10, 2025 | prnewswire.comWeiss Ratings Reiterates "Sell (D-)" Rating for Cytokinetics (NASDAQ:CYTK)October 9, 2025 | marketbeat.comCYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CytokineticsOctober 9, 2025 | prnewswire.comROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTKOctober 9, 2025 | prnewswire.comClass Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join – Contact Levi & KorsinskyOctober 9, 2025 | globenewswire.com Get Cytokinetics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYTK Media Mentions By Week CYTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTK News Sentiment▼0.080.50▲Average Medical News Sentiment CYTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTK Articles This Week▼3516▲CYTK Articles Average Week Get the Latest News and Ratings for CYTK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cytokinetics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BioNTech News Teva Pharmaceutical Industries News Genmab A/S News Summit Therapeutics News Ascendis Pharma A/S News Dr. Reddy's Laboratories News Viatris News Roivant Sciences News QIAGEN News Elanco Animal Health News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYTK) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Republican party is falling apartSomething unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTK Stock Alerts